[HTML][HTML] Molecular BCR::ABL1 Quantification and ABL1 Mutation Detection as Essential Tools for the Clinical Management of Chronic Myeloid Leukemia Patients …
AM Marin, DK Wosniaki, HBS Sanchuki… - International Journal of …, 2023 - mdpi.com
Chronic myeloid leukemia (CML) is a well-characterized oncological disease in which
virtually all patients possess a translocation (9; 22) that generates the tyrosine kinase BCR …
virtually all patients possess a translocation (9; 22) that generates the tyrosine kinase BCR …